Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial
Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPage revision tag updated from v3.4.1 to v3.4.2; no substantive content or layout changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and revision v3.4.0 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 in the revision section; this is a small maintenance detail with no user-facing impact. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded an extensive Locations section listing study sites by state and updated to Revision: v3.3.3. Removed the prior state-specific location blocks (Arizona Locations, California Locations, etc.).SummaryDifference2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This appears to be a backend version update with no visible changes to study content or page layout.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page shows Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.